Commonly referenced guidance includes: Initial replacement Maintenance For maintenance, the BNF lists adult prophylaxis/maintenance dosing such as 1 mg intramuscularly every 23 months in appropriate cases
Pricing sits higher at approximately $140 per bottle, reflecting the more complex formulation and delivery system
The Lancet (2021) This Phase 2 dose-finding trial randomized adults with overweight or obesity without diabetes to cagrilintide at doses from 0.3 to 4.5 mg weekly, placebo, or liraglutide 3.0 mg daily as an active comparator across 57 sites in 10 countries
Both peptides are increasingly being studied in Western academic and independent research contexts, but neither has completed the FDA drug approval process for human use
Y., Channual, J
[DOI] [PubMed] [Google Scholar] 99.Petrovic I., Dobric I., Drvis P., Shejbal D., Brcic L., Blagaic A.B., Batelja L., Kokic N., Tonkic A., Mise S., et al